Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

The Role of ARV Associated Adverse Drug Reactions in Influencing Adherence Among HIV-Infected Individuals: A Systematic Review and Qualitative Meta-Synthesis.

Li H, Marley G, Ma W, Wei C, Lackey M, Ma Q, Renaud F, Vitoria M, Beanland R, Doherty M, Tucker JD.

AIDS Behav. 2017 Feb;21(2):341-351. doi: 10.1007/s10461-016-1545-0. Review.

PMID:
27613645
2.

A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.

[No authors listed]

AIDS Res Hum Retroviruses. 2016 Aug;32(8):772-81. doi: 10.1089/AID.2015.0294. Epub 2016 May 3.

PMID:
27030657
3.

Prevalence of Primary HIV Drug Resistance in Thailand Detected by Short Reverse Transcriptase Genotypic Resistance Assay.

Kiertiburanakul S, Pinsai S, Chantratita W, Pasomsub E, Leechawengwongs M, Thipmontree W, Siriyakorn N, Sungkanuparph S.

PLoS One. 2016 Feb 1;11(2):e0147945. doi: 10.1371/journal.pone.0147945. eCollection 2016.

4.

Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.

Panichsillapakit T, Smith DM, Wertheim JO, Richman DD, Little SJ, Mehta SR.

J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):228-36. doi: 10.1097/QAI.0000000000000831.

5.

In vitro antiretroviral activity and in vivo toxicity of the potential topical microbicide copper phthalocyanine sulfate.

Styczynski AR, Anwar KN, Sultana H, Ghanem A, Lurain N, Chua A, Ghassemi M, Novak RM.

Virol J. 2015 Aug 30;12:132. doi: 10.1186/s12985-015-0358-5.

6.

Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals.

Jiamsakul A, Chaiwarith R, Durier N, Sirivichayakul S, Kiertiburanakul S, Van Den Eede P, Ditangco R, Kamarulzaman A, Li PC, Ratanasuwan W, Sirisanthana T; TREAT Asia Studies to Evaluate Resistance--Monitoring Study TASER-M.

J Med Virol. 2016 Feb;88(2):234-43. doi: 10.1002/jmv.24320. Epub 2015 Jul 17.

7.

Transmission Networks of HIV-1 Among Men Who Have Sex With Men in East and Southeast Asia.

Tee KK, Kantor R, Sungkanuparph S, Takebe Y, Li P, Ditangco R, Phanuphak P, Sirisanthana T, Sim B, Ratanasuwan W, Kantipong P, Kamarulzaman A; TREAT Asia Studies to Evaluate Resistance-Monitoring (TASER-M) Database.

J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):e28-30. doi: 10.1097/QAI.0000000000000614. No abstract available.

8.

Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.

Diallo K, Zheng DP, Rottinghaus EK, Bassey O, Yang C.

AIDS Res Hum Retroviruses. 2015 May;31(5):564-75. doi: 10.1089/AID.2014.0168. Epub 2015 Feb 5.

9.

Genotypes and transmitted drug resistance among treatment-naive HIV-1-infected patients in a northwestern province, China: trends from 2003 to 2013.

Zhao K, Kang W, Liu Q, Li Y, Liu Q, Jiang W, Zhuang Y, Guo Z, Yu Z, Li X, Wang C, Yao N, Sun Y.

PLoS One. 2014 Oct 15;9(10):e109821. doi: 10.1371/journal.pone.0109821. eCollection 2014.

10.

Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia.

Phanuphak P, Sirivichayakul S, Jiamsakul A, Sungkanuparph S, Kumarasamy N, Lee MP, Sirisanthana T, Kantipong P, Lee C, Kamarulzaman A, Mustafa M, Ditangco R, Merati T, Ratanasuwan W, Singtoroj T, Kantor R.

J Acquir Immune Defic Syndr. 2014 May 1;66(1):74-9. doi: 10.1097/QAI.0000000000000108.

11.

Molecular characterization of ambiguous mutations in HIV-1 polymerase gene: implications for monitoring HIV infection status and drug resistance.

Zheng DP, Rodrigues M, Bile E, Nguyen DB, Diallo K, DeVos JR, Nkengasong JN, Yang C.

PLoS One. 2013 Oct 17;8(10):e77649. doi: 10.1371/journal.pone.0077649. eCollection 2013.

12.

Rilpivirine resistance-associated mutations among antiretroviral-naive patients infected with HIV-1 in Asia.

Sungkanuparph S, Jiamsakul A, Kiertiburanakul S, Sirivichayakul S, Praparattanapan J, Kantor R; TREAT Asia Studies to Evaluate Resistance.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):e98-100. doi: 10.1097/QAI.0b013e31827a34b2. No abstract available.

13.

Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa.

Land S, Zhou J, Cunningham P, Sohn AH, Singtoroj T, Katzenstein D, Mann M, Sayer D, Kantor R.

J Int AIDS Soc. 2013 Jul 10;16:18580. doi: 10.7448/IAS.16.1.18580.

14.

Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients.

Kiertiburanakul S, Chaiwarith R, Sirivichayakul S, Ditangco R, Jiamsakul A, Li PC, Kantipong P, Lee C, Ratanasuwan W, Kamarulzaman A, Sohn AH, Sungkanuparph S; TREAT Asia Studies to Evaluate Resistance Surveillance and Monitoring Studies.

PLoS One. 2013 Jun 27;8(6):e62057. doi: 10.1371/journal.pone.0062057. Print 2013.

15.

Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B.

Oyomopito RA, Li PC, Sungkanuparph S, Phanuphak P, Tee KK, Sirisanthana T, Kantipong P, Oka S, Lee CK, Kamarulzaman A, Choi JY, Sohn AH, Law M, Chen YM; TREAT Asia Studies to Evaluate Resistance (TASER) and The TREAT Asia HIV Observational Database.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):293-300. doi: 10.1097/QAI.0b013e31827a2e8f.

16.

Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis.

Jiamsakul A, Kantor R, Li PC, Sirivichayakul S, Sirisanthana T, Kantipong P, Lee CK, Kamarulzaman A, Ratanasuwan W, Ditangco R, Singtoroj T, Sungkanuparph S; TREAT Asia Studies to Evaluate Resistance – Monitoring Study (TASER-M).

BMC Res Notes. 2012 Oct 24;5:582. doi: 10.1186/1756-0500-5-582.

17.

Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review.

Stadeli KM, Richman DD.

Antivir Ther. 2013;18(1):115-23. doi: 10.3851/IMP2437. Epub 2012 Oct 10. Review.

18.

Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India.

Sinha S, Ahmad H, Shekhar RC, Kumar N, Dar L, Samantaray JC, Sharma SK, Bhargava A, Pandey RM, Mitsuyasu RL, Fahey JL.

AIDS Res Treat. 2012;2012:905823. doi: 10.1155/2012/905823. Epub 2012 Mar 15.

19.

Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010.

Karlsson A, Björkman P, Bratt G, Ekvall H, Gisslén M, Sönnerborg A, Mild M, Albert J.

PLoS One. 2012;7(3):e33484. doi: 10.1371/journal.pone.0033484. Epub 2012 Mar 20.

20.

Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand.

Sungkanuparph S, Sukasem C, Kiertiburanakul S, Pasomsub E, Chantratita W.

J Int AIDS Soc. 2012 Mar 12;15(1):12. doi: 10.1186/1758-2652-15-12.

Supplemental Content

Support Center